Navigation Links
ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Date:7/29/2010

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements."  Such statements include, but are not limited to, references to (i) ANA598's initial SVR12 profile based on the results from the six patients in this first group; (ii) the potential for HCV patients to be successfully treated with shortened courses of treatment, reflecting the continuing benefit of ANA598 post-therapy; (iii) the belief that ANA598 is one of the most attractive agents in Phase II HCV development today; (iv) the expected timing for post-treatment results from the other dose groups; and (v) the ability for patients to achieve an SVR in the Phase II combination study.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues or will continue to have favorable results as the Phase II trial progresses. In addition, Anadys' results may be affected by competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments and its ability to obtain additional funding to support its operations.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, includ
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Decision Resources Group finds that the markets for peripheral ... Russia , India ... see robust expansion as these economies expand and as ... revenues will be somewhat impeded by poor distribution of ... and demand for low-cost products, the market will ultimately ...
(Date:9/30/2014)... , Sept. 30, 2014  Decision Resources Group finds that the ... Australia , China , India ... at a strong rate through 2023. Dental implant procedure volumes will ... patient awareness rises. Other key findings from Decision Resources ... implant market: , Dental implant penetration: Penetration of ...
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
Breaking Medicine Technology:Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
... 2012  Based on its recent analysis of the ... recognizes Sensear with the 2012 North American Frost ... its "high-noise communication" devices, including earplugs and earmuffs ... still enabling the user to remain fully aware ...
... Carla Corkern, Chief Executive Officer at Talyst , was ... recognizes entrepreneurs whose ingenuity, hard work and perseverance have created ... originated in 1986 and has grown to 26 programs in ... the world. "Talyst is a leader in ...
Cached Medicine Technology:Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
(Date:9/30/2014)... (PRWEB) September 30, 2014 Glycodrive ... Star Nutraceuticals designed to help maximize lean, strong muscle ... the body’s absorption of glucose has caught the attention ... “The main purpose behind Glycodrive is to help the ... muscle,” reports Michaels. “Carbs are essential in the muscle-building ...
(Date:9/30/2014)... EverStryke , the permanent match currently ... along with a free book and class all about survival ... prompting an investigative review. , “Joe Marshall of SurvivalLife.com ... and preparation niche, and this product is an excellent way ... survival products that Joe offers on his website to help ...
(Date:9/30/2014)... NV (PRWEB) September 30, 2014 Fat ... nutrition specialist and best-selling author Mike Geary that is helping ... transform their body into a fat-burning machine in less than ... an investigative review. , “In our culture that is ... be hard to decipher what is really fact and fiction ...
(Date:9/30/2014)... Las Vegas, NV (PRWEB) September 30, 2014 ... that is helping people perform better in and out of ... performance, and memory has caught the attention of Shane Michaels, ... the day-to-day grind, fatigue is the reason most people simply ... want, whether that means staying focused at work, getting the ...
(Date:9/30/2014)... The American Diabetes Association touts ... their sweet tooth, but the most recent research, published ... that zero-calorie sweeteners may actually be linked to an ... Weizmann Institute of Science in Israel recently discovered ... the mice developed glucose intolerance. They then analyzed data ...
Breaking Medicine News(10 mins):Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2
... April 21 Autism Support Network ( ... Foundation, Inc. ( http://www.aacfinc.org ) ... help reduce the financial burden experienced by families coping ... necessary assistance for their autistic loved ones. As part ...
... , ... Morrisville, NC (PRWEB) April 21, 2009 -- ... Carolina,s Triangle region, has launched the RadarFind Real Time Location ... as a development partner since April 2008, the hospital is sharing ...
... help pharmaceutical companies find, evaluate and manage drug ... the drug development lifecycleSAN FRANCISCO, April 21 ... development partnering site for the pharmaceutical development and ... and website, goBalto.com. goBalto transforms the way drug-development ...
... study indicating that 98% of breast cancer patients are satisfied with ... , Dr. Bob Basu explains why breast reconstruction following a mastectomy ... ... Houston TX (Vocus) April 21, 2009 -- The American Society of ...
... a new medical billing company, announces services that help medical professionals ... changes to the healthcare industry. , ... (PRWEB) April ... has called upon the nation,s healthcare system to step up efforts ...
... health databank promise to speed scientific discovery.MILWAUKEE, April ... announces the launch of its ... ORBIT . This dynamic research instrument may ... widely diverse library of specimens to be used ...
Cached Medicine News:Health News:Autism Support Network and Aid for Autistic Children Foundation, Inc. Create Alliance to Help Families Affected by Autism 2Health News:Autism Support Network and Aid for Autistic Children Foundation, Inc. Create Alliance to Help Families Affected by Autism 3Health News:WakeMed Shares Best Practices for Tracking Assets, Patients 2Health News:WakeMed Shares Best Practices for Tracking Assets, Patients 3Health News:WakeMed Shares Best Practices for Tracking Assets, Patients 4Health News:Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com 2Health News:Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com 3Health News:Houston Plastic Surgeon Cites ‘Therapeutic' Benefits for Women that Choose Breast Reconstruction After Mastectomy 2Health News:Houston Plastic Surgeon Cites ‘Therapeutic' Benefits for Women that Choose Breast Reconstruction After Mastectomy 3Health News:Dr. America Comes to Obama's Aid, Helps Doctors Digitize 2Health News:Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument 2Health News:Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument 3
... Trappers are ideal for use with custom ... Finger Trappers' non-slip foam lining replaces fingernail ... in traction. These are truly the "No ... packages of 5 and boxes of 25. ...
One splint does it all....
... heavy duty, controlled stretch knee brace provides ... or for those individuals with a history ... metal bars provide excellent side-to-side support, yet ... The elastic sleeve supports the entire knee ...
... is a heavy duty, controlled stretch knee ... pain while allowing full range of motion. ... bend with the knee, and help to ... wearing comfort. This is an excellent ...
Medicine Products: